Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-26-201426
Filing Date
2026-05-01
Accepted
2026-05-01 16:08:43
Documents
20

Document Format Files

Seq Description Document Type Size
1 S-3 d79008ds3.htm S-3 339004
2 EX-4.12 d79008dex412.htm EX-4.12 282151
3 EX-4.13 d79008dex413.htm EX-4.13 285751
4 EX-5.1 d79008dex51.htm EX-5.1 28769
5 EX-23.1 d79008dex231.htm EX-23.1 1535
6 EX-23.2 d79008dex232.htm EX-23.2 1800
7 EX-FILING FEES d79008dexfilingfees.htm   iXBRL EX-FILING FEES 41426
8 GRAPHIC g79008dsp130.jpg GRAPHIC 4392
9 GRAPHIC g79008g00x03.jpg GRAPHIC 39073
10 GRAPHIC g79008g00x23.jpg GRAPHIC 34617
11 GRAPHIC g79008g00x24.jpg GRAPHIC 35349
  Complete submission text file 0001193125-26-201426.txt   1317801

Data Files

Seq Description Document Type Size
23 EXTRACTED XBRL INSTANCE DOCUMENT d79008dexfilingfees_htm.xml XML 20567
Mailing Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612
Business Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-295498 | Film No.: 26932546
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)